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Abstract 
A 659 bp cDNA clone** coding for an allergen of Pj pollen has been isolated from a lambda gt 11 library, and its DNA sequence determined. The 
cDNA insert showed an open reading frame of 429 bp coding for an allergenic protein of 14,866 Da and a deduced amino acid sequence containing 
143 residues. The expressed recombinant protein represented the major allergen Par j I since it reacted with 95% of the sera from Pj-allergic patients 
(n = 22) and with two Par j I-specific monoclonal antibodies. No similarity with other known DNA and protein sequences has been detected. 
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1. Introduction 
Basic and clinical research as well as the diagnosis of 
allergy is usually hindered by the low amount of pure 
allergens available. 
To overcome this limitation mRNA, isolated from dif- 
ferent allergenic sources, is now used to generate cDNA 
libraries, and several recombinant allergens have been 
isolated [l-6]. However, to date a cloned Par&aria aller- 
gen has been not yet reported. 
The pollen of the weed Parietariu is the main cause of 
allergic reactions in the Mediterranean countries [7-S], 
representing about 40% of the cases in pollen-allergic 
sensitive patients [9]. Its diffusion is not restricted to the 
Mediterranean area since ? judaica and I! officinalis 
have also been reported as a cause of allergic reactions 
in Eastern Australia [lo], and in the United States respec- 
tively [ll]. 
The allergenic composition of the Purietaria pollen 
has been studied [12-141 and the E! juduica aqueous 
extract is composed of a complex mixture of at least 26 
antigens, 9 of which have been shown to bind specifically 
to IgE of allergic patients using either CRIE [15] or 
immunoblotting after transfer of SDS-PAGE separated 
*Corresponding author. Fax: (39) (91) 6165665. 
**EMBL data bank accession number X77414. 
Abbreviations: Pj, Parietaria judaica; CRIE, crossed radio immunoelec- 
trophoresis; IPTG, isopropylthio-p-D-galactoside. 
proteins [16]. Among the 9 allergens, a major allergen 
named Par j I, has been purified to homogeneity by 
means of monoclonal antibody affinity chromatography 
and HPLC [17]. The purification of biologically active 
mRNA from Pj inflorescence and the sequence of the 
twelve N-terminal residues of the II officinalis major 
allergen has been reported [ 18,191, while two Par j I 
isoforms have been recently separated and the partial 
N-terminal sequence reported. [20]. In this paper wede- 
scribe for the first time the cloning, expression and se- 
quencing of a cDNA encoding the major allergen Par j 
I, its deduced amino acid sequence and the allergenic 
activity. 
2. Materials and methods 
2.1. Total andpoIy(A)+ mRNA preparation 
Inflorescence of Pj were collected from weeds flowering in Palermo 
Italy, and powdered after freezing in liquid nitrogen with a mortar and 
pestle. 
The total RNA from the flowers was extracted as reported [21], with 
minor modifications. In short: the Pj-inflorescence powders were ho- 
mogenised by vortexing with glass beads in lysis buffer (2% SDS, 1% 
2-mercaptoethanol, 50 mM EDTA, 150 mM T&borate, pH 7.5), 3 ml 
buffer/g tissue and quickly mixed with 0.25 buffer volume of 100% 
ethanol and 0.9 buffer volume of 5 M potassium acetate (K+). The 
mixing was performed for 1 min followed by chloroform extraction and 
centrifugation at 4°C for 30 min at 10,000 rpm. 
The aqueous phase was extracted several times with phenol and 
finally with chloroform. The RNA was precipitated from the aqueous 
phase with 3 M LiCl containing 1% 2-mercaptoethanol (v/v), at - 10” C 
overnight. The RNA was collected by centrifugation, and the pelletdis- 
solved in 0.5 x lysis buffer plus ethanol/K’ and extracted once in chloro- 
form. Phenol/chloroform extractions were repeated several times until 
a clear interphase was obtained. One volume of 12M LiCl was added 
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to the aqueous phase and left overnight at - lO”C, then centrifuged and 
the pellet dissolved was again precipitated with 0.3 M sodium acetate, 
pH 5.5. After centrifugation, the pellet was resuspended in 1 ml H,O. 
The solution was denatured at 65’C for 5 min in one volume of 2 x BB 
buffer (10 mM Tris pH 7.6,0.5 M NaCl, 0.1% SDS), and chromatogra- 
phed several times through a cellulose column previously sterilised with 
0.3 N NaOH and equilibrated with 1 x BB buffer. The total RNA was 
eluted with 1 x BB buffer. 
Poly(A)’ mRNA was isolated by loading the total RNA solution 
onto an oligo(dT)-cellulose column (Sigma, St. Louis, MO), following 
the standard procedures reported [22]. 
2.2. cDNA library immunological screening and cDNA sequencing 
Double strand cDNA was synthesised from mRNA using oligo dT 
primer and cloned into the EcoRI site of the phage vector lambda gtl 1, 
according to published procedures in the Amersham cDNA cloning kit 
(Amersham Corp., Arlington Heights, IL). 
In brief, a cDNA library containing approximately 5x 10’ recombi- 
nant phages was constructed. 4 x lo5 plaques were immunologically 
screened using pooled sera (n = 10) from patients allergic to Pj pollen 
and five positive IgE binding plaques were obtained. The sera from 
Pjallergic patients were tested with a radioallergosorbent test QAST, 
Pharmacia, Sweden) and only sera with class four values were pooled 
and used in the experiments described in this paper. None of the five 
immunoreactive plaques showed any positive crossreactivity with sera 
from non-allergic subjects. Protein expression was induced and lysates 
prepared as described [23]. The nucleotide sequence of the cDNA insert 
was determined on both strands of pBluescript KS by the dideoxy 
sequencing procedure [24]. 
2.3. Western blot analysis 
The lysates were separated by electrophoresis on a 10% SDS-PAGE 
gel, electroblotted to nitrocellulose filters and subsequently blocked for 
3 h at room temperature in PBS, 3% BSA, 0.5% Tween and 0.02% NaN, 
and washed using PBS, 0.1% Tween solution. 
The filters were immunoscreened using pooled sera from Pj-allergic 
and non-allergic subjects as a control and with two Par j I-specific 
monoclonal antibodies [17,25]. The monoclonals were diluted 1:5,000 
in PBS, 0.25% BSA, 0.1% Tween and 0.02% NaN, and incubated at 
room temperature for 3.5 h, while the Pj-allergic and control non- 
allergic sera were diluted 1:5 in the same buffer. IgE- and IgG-allergen 
bound complexes were radio labelled using 5 x lo5 cpm/ml rabbit anti- 
human IgE ‘*‘I (Pharmacia, Sweden) and 17 x 10’ cprn/ml sheep anti- 
mouse IgG ‘25I (Amersham, UK), respectively, in PBS containing 
0.25% BSA, 0.1% Tween and 0.2% NaN,. The filters were extensively 
washed after every step in PBS and the radio labelled IgE-allergen or 
IgG-allergen complexes were detected by autoradiography. 
2.4. Dot blot analysis 
The same amount of the lambda gtll P5 was spotted on a confluent 
Y1090 plate and left at 43’C until a small lysis plaque was visible (3 
h). The wild type lambda gtl 1 was used as a negative control. A filter 
of nitrocellulose was then immersed in 10 mM IPTG, laid on the plate 
and transferred at 37°C for 4 h to induce the recombinant PS-B-galac- 
tosidase protein. The filters were blocked and treated as above de- 
scribed. 
2.5. Northern blot analysis 
The total cellular and poly(A)+ RNAs have been prepared as de- 
scribed above [21,22]. RNAs were fractionated on a 1% agarose-for- 
maldehyde gel and transferred to Hybond-N filters as recommended by 
manufactures. The hybridisation was carried out at 65°C as reported 
[26] and the filters were washed under high stringency conditions. 
3. Results and discussion 
The total RNA was isolated from Pj-flowers with a 
yield of about 0.5 mg per gram of wet flowers. The 
poly(A)’ mRNA purified by affinity chromatography 
was used as template to synthesise the complementary 
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Fig. 1. Comassie blue stained gel of total cell lysates of P5 lambda gtl 1 
clone. Lane A: molecular weight markers; lane B: non-induced recom- 
binant lysates; lane C: induced recombinant lysates. 
DNA, 20 ng of cDNA were used for constructing a 
Pj-specific cDNA library in the expression vector lambda 
gtll. About 4 x 10’ plaque-forming units of recombi- 
nant phages were immunoscreened for IgE-reactive pla- 
ques by using sera (n = 10) from patients allergic to Pj 
pollen and five putative positive clones were found dur- 
ing the first screening. The screening with non-allergic 
sera (n = 10) used as a control, gave no positive reaction. 
One of five positive clones, designated as P5, was further 
used to induce a recombinant fusion protein. 
From the recombinant P5 clone, an approximately 129 
kDa PS-B-galactosidase fusion protein can be visualised 
in the total cell lysate after IPTG induction (Fig. 1, lane 
C). The 129 kDa recombinant protein was composed of 
a 114 kDa fragment of B-galactosidase fused to the P5 
protein. Lane B shows a total cell lysates from recombi- 
nant P5 clone without induction, while on Lane A a pool 
of protein markers (range 45-200 kDa) was used. 
Fig. 2 panel A represents a Western blot of the same 
cell lysates from the recombinant P5 clone showed in Fig. 
1. Lanes 1 and 2 show immunoblot screened with pooled 
allergic sera with non-induced and induced P5 protein, 
respectively. Only the induced sample was capable of 
binding with the Pj-allergic sera. Lane 3 represents apool 
of protein markers including the /3-galactosidase protein 
as a control and used at the same concentration as in Fig. 
1. No IgE-binding activity was detected for this protein 
confirming that the PS-cDNA clone itself encoded for an 
IgE-reactive allergen. Lanes 4 and 5 are immunoblots of 
non-induced and induced P5 clones screened with a pool 
of non-allergic sera. No IgE complexes were found sup- 
porting the specificity of the immuno reaction reported 
above. A high number of antigens (n = 26) of the Pj 
pollen has been already partially characterised [15-161. 
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Fig. 2. SDS-PAGE gel of total cell lysates from recombinant E. Coli. (Panel A) lane 1: non-induced recombinant lysates; lane 2: induced recombinant 
lysates; lane 3: molecular weight markers; Lanes 1, 2 and 3 were immunoblotted using a pool of sera (n = 22) from Pj-allergic patients; lane 4: 
non-induced recombinant lysates; lane 5: induced recombinant lysates; lanes 4 and 5 were immunoblotted using a pool of sera (n = 10) from 
non-allergic subjects. (panel B) lane 6: non-induced recombinant lysates; lane 7: induced recombinant lysates; Lane 8: molecular weight markers; 
lane 9: non-induced recombinant lysates; lane 10: induced recombinant lysates; lane 11: molecular weight markers. Panel B lanes were immunoblotted 
using two different monoclonal antibodies specific for the Par j I major allergen (see section 2 for details). 
At least 9 of them were capable of binding specific 
human IgE and 4 were classified as major allergens [15- 
16]. To evaluate which of them we had isolated, we per- 
formed an immunoblot screened with two monoclonal 
antibodies specific for the Par j I allergen [17,25] and the 
result is reported in Fig. 2 panel B. Lanes 6 and 9 show 
non- induced total cell lysates, lanes 7 and 10 the induced 
total cell lysates, while lanes 8 and 11 the molecular 
weight markers. The very specific immunoreaction be- 
tween the induced P5 protein and the two monoclonal 
antibodies showed in lanes 7 and 10, demonstrated that 
the PS- cDNA clone encoded for the major allergen Par 
j I. In addition, to study the clinical relevance and diffu- 
sion of the P5 expressed protein, 22 sera from patients 
not in therapy and allergic to the Pj pollen, were individ- 
ually tested in a dot blot assay (see section 2 for details). 
Of all the sera, 95% showed a strong IgE-binding interac- 
tion suggesting that the P5 expressed protein clearly rep- 
resents a major allergen. The negative IgE-interaction 
observed for the remaining 5% of the sera could be due 
to the possibility that they did not share any IgE specific 
for the Par j I, or that the recombinant echnology made 
the P5 protein unreactive versus some specific allergic 
sera. These results are in agreement with those obtained 
using the native Par j I capable of reacting with 95-100% 
of the Pj-allergic sera [15-161. The cDNA insert of the 
P5 clone was then excised from the lambda gtll phage 
after EcoRI digestion and subcloned into pBluescript KS 
(Stratagene). The DNA sequence analysis revealed a 659 
bp cDNA clone (Fig. 3) with an open reading frame of 
429 nucleotides and with a deduced amino acid sequence 
of 143 residues (starting from the fist methionine). The 
P5 clone also showed a 185 bp 3’ untraslated region with 
a canonical poly(A)’ tail at the end. The molecular 
weight of the P5 protein is of 14,866 kDa which corre- 
sponds to the previously detected molecular weight of 
the native Par j I allergen [16]. To confirm that the P5 
clone represented a full length clone, a Northern blot 
from total and poly(A)’ RNAs from Pj flowers has been 
performed. Fig. 4 shows the hybridisation pattern and 
the native size of the P5 clone mRNA (lanes A and B). 
The band showed a size of about 650 bp as expected. The 
RNAs used in lanes A and B were nucleic acids from 
flowers collected in May, while lanes C and D collected 
in January. Lanes A,B and C,D showed a different level 
of expression suggesting that the P5 cDNA clone has a 
pattern of expression as expected for a seasonal flower- 
ing plant. 
In conclusion in this paper we describe the isolation 
and characterisation of the cDNA clone coding for the 
major allergen Par j I. A recent paper published by 
Ayuso et al. [20] reports the NH,-terminal sequence of 
two Parj I isoforms (Parj I A: 17 a.a.; ParjI B: 19 a.a.). 
The comparison of the two short reported sequences 
with the P5 protein showed a region of high homology 
starting from the 10th amino acid residue of the isoform 
A. The differences observed in the remaining region 
could be due to the different isoforms analysed by the 
two groups or to intraspecie variation. 
The data presented in this paper might represent a 
useful step towards further basic and clinical research on 
the Parietaria-induced allergy. The primary structure of 
the ParJl, one of the major allergenic molecule of the Pj 
pollen, would allow the preparation of synthetic peptides 
useful for either B and T epitope detection. Cell culture 
and animal studies suggest that peptides representing 
epitopes on allergen can be used to induce tolerance to 
allergens. Administration of these substances to patients 
MA. Costa et al. IFEBS Letters 341 (1994) 182-186 
MVRALUPCLPFV 
gaattcCAAGAAACCTGCGGGACTATGGTGAGAGCGCTGATGCCGTGCCTGCCGTTCGTG 
60 
185 
QGKEKEPSKGCCSGAKRLDG 
CAGGGGAAAGAGAAAGAGCCGTCAAAGGGGn;Cn;CAGCG 
120 
ETKTGPQRVHACECIQTAMK 
GAGAcGAAGACGGGGCCGCAGAGGGTGCA C CTTGTGAGTGC!ATC!CAGACCGCC!ATGAAG 
180 
TYSDIDGKLVSEVPKHCGIV 
ACTTATTCCGACATCGACGGGAAA CTCGTCAGCGAGGTCCCCAAGCACTGCGGCATCGTT 
240 
DSKLPPIDVNMDCKTLGVVP 
GACAGC!AAGCTCCCGC!C!CATTGACGTCAACATGGAC!TGCAAGACAGTTGGAGTGGTTCCT 
300 
RQPQLPVSLRHGPVTGPSRS 
CGGCAACCCCAACTTCCAGTCTCTCTCCGTCATGGTCCCGTCACGGGCCCAAGTCGATCC 
360 
RPPTKRGWRDPRLEFRPPBR 
CGCCCGCCCACAAAGCACGGTTGGAGAGACCCCAGATTAGAGTTCCGCCCCCCGCACCGG 
420 
KKPNPAFSTLG 
AAAAAGCCTAACCCAGCTTCCACTCTTGGA~GCGAGGCTAATATTATTAAGCCCT 
480 
AAACTCTAATGACGGTGGAACTGTGTTATGAGAAGl'TATATGCAATAATTATCTTAATAT 
540 
ATATATATATATATATAGTTGACTAGTGAGTAGTGACATCATTCACGTAATAAATAATGT 
600 
GTACTTTACTTATCGATATAATGATTAAAGATATGTTGATT~gaattc 
659 
Fig. 3 Nucleotide and deduced amino acid sequences of the P5 cDNA coding for the Par j I allergenic protein. Numbers in the right margin refer 
to positions of the nucleotides. The deduced amino acid sequence is shown by one-letter code above the corresponding codon. Lower case letters 
show the EcoRI cloning site. The underlined trinucleotide showsthetermination codon. 
can down regulate T cells and the consequent inflamma- 
tory response and greatly reduce the risk of anaphylaxis 
that the standard immunotherapy may induce. The re- 
combinant allergen could also be a good tool for further 
immunochemical studies and for the diagnosis of the 
most widespread Mediterranean allergy to pollen. 
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Fig. 4 Northern blot analysis of Parietaria judaica RNA flowers. Lane 
A: 0.5 pg of poly(A)+RNA, lane B: 20 pg of total RNA; lane C: 0.5 fig 
of poly(A)‘RNA, lane D: 20 pg of total RNA. Lanes A and B show 
RNAs from flowers collected in May, Lanes C and D in January. 
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